479 multicenter feasibility study of combined injection and argon plasma coagulation (hybrid-apc) in the ablation therapy of neoplastic barrett esophagus

After endoscopic resection of visible neoplasia in Barrett esophagus (BE), the remaining BE mucosa is currently treated by ablation therapy to eradicate the entire BE. For ablation, radiofrequency ablation (RFA) has been used in most studies, but argon plasma coagulation (APC) had recently been introduced in a combination with prior submucosal injection (Hybrid-APC, H-APC) and reached promising results in a small pilot study.

Source: Gastrointestinal Endoscopy - May 30, 2018 Category: Gastroenterology Authors: Thomas R ösch, Hendrik Manner, Andrea May, Mate Knabe, Guido Schachschal, Hanno Ehlken, Horst Neuhaus, Torsten Beyna, Jennis Kandler, Jacques Bergman, Bas L. Weusten, Oliver Pech, Siegbert Faiss, Mario Anders, Christian Ell Tags: Oral abstract Source Type: research